Literature DB >> 27033280

A neoteric multidrug combination: novel approach to limited cutaneous systemic scleroderma involving the face.

M Hari Kumar1, M Siva Kumar2, Sabitha Hari Kumar1, Kingsly Selva Kumar1.   

Abstract

Limited cutaneous scleroderma is a subtype of scleroderma limited to the skin of the face, hands, feet and forearms. We present a case of a 45-year-old woman affected by limited cutaneous systemic scleroderma involving the orofacial region and causing restricted mouth opening. The patient showed noteworthy improvement of the skin lesion by use of a combination of intralesional corticosteroid with hyaluronidase and various multiantioxidants, resulting in amelioration of her mouth opening problem. The patient gave her full informed written consent to this report being published. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27033280      PMCID: PMC4840643          DOI: 10.1136/bcr-2015-212787

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  23 in total

Review 1.  My approach to the treatment of scleroderma.

Authors:  Ami A Shah; Fredrick M Wigley
Journal:  Mayo Clin Proc       Date:  2013-04       Impact factor: 7.616

Review 2.  Use of hyaluronidase for pharmacokinetic increase in bioavailability of intracutaneously applied substances.

Authors:  Johannes Wohlrab; David Wohlrab; Lukas Wohlrab; Christiane Wohlrab; Angelika Wohlrab
Journal:  Skin Pharmacol Physiol       Date:  2014-06-18       Impact factor: 3.479

3.  Role of the free radical release process in the pathogenesis of morphea in contrast to systemic sclerosis.

Authors:  A A Shahin; S M Esmat; O G Shaker; H A Moustafa
Journal:  Mod Rheumatol       Date:  2001-12       Impact factor: 3.023

Review 4.  Corticosteroids: Mechanisms of Action in Health and Disease.

Authors:  Sivapriya Ramamoorthy; John A Cidlowski
Journal:  Rheum Dis Clin North Am       Date:  2016-02       Impact factor: 2.670

5.  Diet in dermatology: present perspectives.

Authors:  K H Basavaraj; C Seemanthini; R Rashmi
Journal:  Indian J Dermatol       Date:  2010 Jul-Sep       Impact factor: 1.494

6.  Trace element supplementation after major burns modulates antioxidant status and clinical course by way of increased tissue trace element concentrations.

Authors:  Mette M Berger; Malcolm Baines; Wassim Raffoul; Messod Benathan; René L Chiolero; Chris Reeves; Jean-Pierre Revelly; Marie-Christine Cayeux; Isabelle Sénéchaud; Alan Shenkin
Journal:  Am J Clin Nutr       Date:  2007-05       Impact factor: 7.045

Review 7.  Small mouths ... Big problems? A review of scleroderma and its oral health implications.

Authors:  Jonathan B Albilia; David K Lam; Nick Blanas; Cameron M L Clokie; George K B Sándor
Journal:  J Can Dent Assoc       Date:  2007-11       Impact factor: 1.316

8.  Clinical and histopathological evaluation of collagen fiber orientation in patients with oral submucous fibrosis.

Authors:  Br Smitha; Mandana Donoghue
Journal:  J Oral Maxillofac Pathol       Date:  2011-05

9.  Modulation of fibrosis in systemic sclerosis by nitric oxide and antioxidants.

Authors:  Audrey Dooley; K Richard Bruckdorfer; David J Abraham
Journal:  Cardiol Res Pract       Date:  2011-10-31       Impact factor: 1.866

10.  Systemic sclerosis: current concepts in pathogenesis and therapeutic aspects of dermatological manifestations.

Authors:  Vishalakshi Viswanath; Meghana M Phiske; Vinay V Gopalani
Journal:  Indian J Dermatol       Date:  2013-07       Impact factor: 1.494

View more
  2 in total

1.  Severe Acro-osteolysis in a Case of Limited Cutaneous Scleroderma.

Authors:  Milad Hosseinialhashemi; Babak Daneshfard; Omid Keshavarzian
Journal:  Iran J Public Health       Date:  2017-01       Impact factor: 1.429

2.  Hyaluronidase injections for treatment of symptomatic pansclerotic morphea-induced microstomia.

Authors:  Laila F Abbas; Jennifer Coias; Heidi T Jacobe; Rajiv I Nijhawan
Journal:  JAAD Case Rep       Date:  2019-09-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.